The Medicine Maker / Issues / 2024 / Articles / Dec / Time Machine
Manufacture Cell & Gene Facilities & Equipment Technology & Manufacturing Supply Chain Business & Trends Sponsored

Time Machine

Step into a future where science fiction meets reality – the world of cell and gene therapies. Discover how cryopreservation, CRISPR, and advanced technologies are transforming lives and forging the future of medicine. Join us as industry experts explore the promises and challenges of the industry’s most cutting-edge therapies – a new adventure in disease eradication.

12/06/2024 1 min read

Sponsored By

Share

Get ready for The Medicine Maker's latest cell and gene supplement. This year's edition gathers a range of experts ready to unleash their insights on the industry’s ongoing development. From a deep dive into the contributions of cryopreservation, to CRISPR, AI, and the development of metabolic conditioning to improve new cell and gene therapy performances. Among the thought leaders contributing this year include Ori Biotech’s Matt Todd, Yelena Bronevetsky and James Lim of Xcell Biosciences, TrakCel CEO Fiona Withey,and Autologous CEO Alexander Seyf. Stop the clocks, take a seat, and discover what’s next in the incredible journey of advanced medicine!

Download here!



Recommended

Related Content

Don’t Forget CDx Developers
Cell & Gene
Don’t Forget CDx Developers

November 7, 2014

0 min read

Many drug developers are going ‘full steam ahead’ with personalized medicine strategies. They would be wise to consider a more equitable business model for an essential partner in the process: the developer of the companion diagnostic.

The Next Decade of Cell and Gene Therapies
Cell & Gene Bioprocessing Biopharma
The Next Decade of Cell and Gene Therapies

April 2, 2025

5 min read

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems, and more; we ask experts about the future of advanced medicine.

Peter Marks Resigns from FDA
Regulation & Standards Business & Trends Cell & Gene
Peter Marks Resigns from FDA

April 1, 2025

3 min read

Resignation letter states: “truth and transparency” around vaccines are not desired by Health Secretary RJK Jr. “Rather he wishes subservient confirmation of his misinformation and lies.”

The Trump Effect on Cell and Gene: Science versus Shockwaves
Business & Trends Regulation & Standards Cell & Gene
The Trump Effect on Cell and Gene: Science versus Shockwaves

April 1, 2025

9 min read

Audrey Greenberg on FDA staffing cuts, Peter Marks’ resignation, CDMO pressure, IP migration, AI acceleration, and what CGT needs now to stay on track.